68.5
Cue Biopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
77.2
FY23:
51.5
FY24:
25.1
FY25:
37.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.9
FY22:
14.1
FY23:
10.1
FY24:
7.05
FY25:
5.23
Total assets
Change from FY21 to FY25
millions USD
FY21:
83.4
FY22:
91.3
FY23:
61.5
FY24:
32.2
FY25:
42.2
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
12.8
FY22:
11.5
FY23:
17.1
FY24:
13.7
FY25:
13.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.12
FY22:
14.1
FY23:
7.36
FY24:
1.00
FY25:
2.29
(positive)
Change from FY21 to FY25
millions USD
FY21:
65.5
FY22:
65.7
FY23:
37.1
FY24:
17.5
FY25:
26.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
83.4
FY22:
91.3
FY23:
61.5
FY24:
32.2
FY25:
42.2
All amounts in millions USD